Evidence map›Paper›PMID 40371109›Full record

ArticleFrontiers in microbiology2025

Sonia Sharma, Aarjoo Sharma, Gurleen Kaur Sodhi, Nancy George, Khaloud Mohammed Alarjani, Arkadeep Mukherjee, Santosh Kumar Rath, Ramandeep Kaur, Vagish Dwibedi

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sonia SharmaUniversity Institute of Biotechnology, Chandigarh University, Mohali, India.
Aarjoo SharmaDepartment of Microbiology, Panjab University, Chandigarh, India.
Gurleen Kaur SodhiUniversity Institute of Biotechnology, Chandigarh University, Mohali, India.
Nancy GeorgeUniversity Institute of Biotechnology, Chandigarh University, Mohali, India.
Khaloud Mohammed AlarjaniDepartment of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Arkadeep MukherjeeDepartment of Civil Engineering, Yeungnam University, Gyeongsan, Republic of Korea.
Santosh Kumar RathSchool of Pharmaceuticals and Population Health Informatics, Faculty of Pharmacy, DIT University, Dehradun, India.
Ramandeep KaurDepartment of Biotechnology, Chandigarh Group of Colleges, Landran, India.
Vagish DwibediUniversity Institute of Biotechnology, Chandigarh University, Mohali, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Probiotics are live bacteria that provides numerous healthy and beneficial effects to the consumers. The present study aimed to investigate the effect of a probiotic candidate Methods: : This probiotic candidate was isolated from a soil sample collected from a region of fruit waste decomposition. Results: An IC50 value of 47.52 ± 0.18 μg/mL and cell shrinkage were observed along with the release of cellular content of THP-1 cells. The higher production of reactive oxygen species and lesser release of interleukins (IL-4, 5, and 13) are attributed to the antiallergic potential of this strain. Furthermore, in vitro cytotoxicity evaluation using 3T3-L1 cells identified this strain as a promising candidate for anti-obesity treatment. The observed IC50 value was 514.4 ± 0.061 μg/mL. Discussion: This extract was shown to have good lipase-inhibiting enzyme activity and was reported to prevent adipogenesis, depicted by increased HDL levels and decreased LDL and triglyceride levels. These results suggested that Staphylococcus epidermidis SAS1 may have therapeutic use in the treatment of obesity and allergies.

Indexed as

allergyobesityprobiotic candidateStaphylococcus epidermidistherapeutic treatment

Identifiers

PMID40371109
PMCPMC12075200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.